Aruma is an Australia-based company licensed by the Office of Drug Control for the cultivation and manufacture of medicinal cannabis. Aruma was founded in 2016 with a mission to produce high-quality cannabis therapeutics and a commitment to delivering positive outcomes for patients, carers, and healthcare professionals.

Aruma is in the final stages of designing its purpose-built cultivation and manufacture facility incorporating industry-leading equipment and technology, with construction to commence in 2019. We believe that forming synergies with key stakeholders throughout the entire value chain enables us to better serve patients, so we seek out and build partnerships with some of the world’s foremost experts in medicinal cannabis.

At Aruma, we believe in unlocking the full therapeutic potential of the cannabis plant, and we are looking forward to ensuring Australian patients have an affordable, high-quality source of medicinal cannabis.


We encourage and reward thought-leadership by empowering our team to be creative and introduce new solutions, methods, and processes.


We are committed to always putting patients and the community first by maintaining and acting with the highest standards of ethics, honesty and respect.


We aim to contribute to the science behind cannabis therapeutics in order to educate medical professionals about the therapeutic benefits of medicinal cannabis.


We strive to reduce the environmental footprint of the cannabis industry by developing and utilising innovative and efficient production methodologies.